Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study

OBJECTIVE: To estimate the risk of non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma (HL) in patients with inflammatory bowel disease (IBD). DESIGN: We undertook a two-country population cohort study with all patients diagnosed with IBD in Norway and Sweden from 1987 and 1993 through 2015 and 2016...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jingru, Refsum, Erle, Wieszczy, Paulina, Helsingen, Lise M, Perrin, Vera, Högdén, Amanda, Løberg, Magnus, Blom, Johannes, Bretthauer, Michael, Adami, Hans-Olov, Ye, Weimin, Kalager, Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163486/
https://www.ncbi.nlm.nih.gov/pubmed/37142293
http://dx.doi.org/10.1136/bmjgast-2022-001037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163486/
https://www.ncbi.nlm.nih.gov/pubmed/37142293
http://dx.doi.org/10.1136/bmjgast-2022-001037

Ejemplares similares